Strs Ohio Makes New Investment in iRadimed Corporation $IRMD

Key Points

• Strs Ohio acquired 10,100 shares of iRadimed Corporation valued at approximately $530,000, representing about 0.08% ownership of the company.
• CEO Roger E. Susi sold 5,000 shares for $356,350, reducing his ownership stake in iRadimed by 0.21%.
• iRadimed recently declared a quarterly dividend of $0.17, resulting in a 1.0% dividend yield and an annualized payout of $0.68.

Strs Ohio acquired a new stake in shares of iRadimed Corporation (NASDAQ:IRMD - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 10,100 shares of the medical equipment provider's stock, valued at approximately $530,000. Strs Ohio owned about 0.08% of iRadimed as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also made changes to their positions in the stock. Ellsworth Advisors LLC acquired a new position in shares of iRadimed during the first quarter valued at about $629,000. Acadian Asset Management LLC raised its position in shares of iRadimed by 10.9% during the first quarter. Acadian Asset Management LLC now owns 156,319 shares of the medical equipment provider's stock valued at $8,197,000 after buying an additional 15,329 shares during the last quarter. Jane Street Group LLC acquired a new position in shares of iRadimed during the first quarter valued at about $369,000. Goldman Sachs Group Inc. raised its position in iRadimed by 1.1% in the first quarter. Goldman Sachs Group Inc. now owns 169,387 shares of the medical equipment provider's stock worth $8,889,000 after purchasing an additional 1,821 shares in the last quarter. Finally, Jones Financial Companies Lllp raised its position in iRadimed by 8,568.5% in the first quarter. Jones Financial Companies Lllp now owns 11,269 shares of the medical equipment provider's stock worth $591,000 after purchasing an additional 11,139 shares in the last quarter. Institutional investors and hedge funds own 92.34% of the company's stock.

iRadimed Trading Up 0.3%

NASDAQ:IRMD traded up $0.19 during mid-day trading on Monday, hitting $70.71. The company's stock had a trading volume of 56,480 shares, compared to its average volume of 42,599. iRadimed Corporation has a fifty-two week low of $46.86 and a fifty-two week high of $74.43. The company has a market capitalization of $899.43 million, a price-to-earnings ratio of 43.65 and a beta of 1.01. The stock has a fifty day moving average of $67.56 and a 200-day moving average of $59.28.

iRadimed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Monday, August 18th were given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend was Monday, August 18th. iRadimed's dividend payout ratio is 41.98%.

Insider Activity

In related news, CEO Roger E. Susi sold 5,000 shares of the stock in a transaction dated Wednesday, September 17th. The shares were sold at an average price of $71.27, for a total value of $356,350.00. Following the completion of the transaction, the chief executive officer owned 2,357,500 shares of the company's stock, valued at $168,019,025. This represents a 0.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Monty K. Allen sold 1,102 shares of the stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $69.10, for a total transaction of $76,148.20. Following the completion of the transaction, the director directly owned 19,898 shares of the company's stock, valued at $1,374,951.80. This trade represents a 5.25% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 36.80% of the company's stock.

iRadimed Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.